Teva, Intel to develop wearables to monitor Huntington’s disease

Ripple raises $55 million in second funding round, adds several banks to network
September 15, 2016
Obama administration targets corporate offshore tax avoidance
September 15, 2016
This post was originally published on this site

(Reuters) – Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable device to monitor patients with Huntington’s, a fatal degenerative disease.